Clinical trial reportThe lancet. HIVPublished
Safety of combined long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study
Regional connection
Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, GSK, Perelman School of Medicine, University of Pennsylvania. Affiliation source
Publication record
- Type
- Clinical trial report
- Venue
- The lancet. HIV
- Published
- Topic
- Clinical care
- Subject terms
- Humans; HIV Infections; Pyridones; Delayed-Action Preparations; Anti-HIV Agents; Treatment Outcome; Drug Therapy, Combination; Viral Load; Injections, Intramuscular; Adolescent; Child; Female
- PubMed ID
- 40049924
- PubMed Central ID
- PMC12087306
- Open access
- Yes, accepted manuscript
- Added to directory
- Source checked